Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P et al (2016) ;13(5):261 – 80. https://doi.org/10.1038/nrgastro.2016.51, PMID: 27095655. https://doi.org/10.1038/nrgastro.2016.51

Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8(9):512–522. https://doi.org/10.1038/nrgastro.2011.131

Article  PubMed  PubMed Central  Google Scholar 

Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15(2):95–111. https://doi.org/10.1038/nrclinonc.2017.157

Article  CAS  PubMed  Google Scholar 

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C et al (2018) Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 29 Cancer groups, 1990 to 2016: a systematic analysis for the global burden of Disease Study. JAMA Oncol 4(11):1553–1568. https://doi.org/10.1001/jamaoncol.2018.2706

Article  Google Scholar 

Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215–1229. https://doi.org/10.1053/j.gastro.2013.10.013

Article  CAS  PubMed  Google Scholar 

Moeini A, Sia D, Bardeesy N, Mazzaferro V, Llovet JM (2016) Molecular Pathogenesis and targeted therapies for Intrahepatic Cholangiocarcinoma. Clin Cancer Res 22(2):291–300. https://doi.org/10.1158/1078-0432.CCR-14-3296

Article  PubMed  Google Scholar 

Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003–1010. https://doi.org/10.1038/ng.3375

Article  CAS  PubMed  Google Scholar 

Weber SM, Ribero D, O’Reilly EM, Kokudo N, Miyazaki M, Pawlik TM (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):669–680. https://doi.org/10.1111/hpb.12441

Article  PubMed  Google Scholar 

Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BSJ et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234(4):507–517 discussion 517-9. https://doi.org/10.1097/00000658-200110000-00010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR et al (2008) Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 34(7):787–794. https://doi.org/10.1016/j.ejso.2007.10.005

Article  CAS  PubMed  Google Scholar 

Yoo T, Park SJ, Han SS, Kim SH, Lee SD, Kim TH et al (2018) Proximal resection margins: more prognostic than distal resection margins in patients undergoing Hilar Cholangiocarcinoma Resection. Cancer Res Treat 50(4):1106–1113. https://doi.org/10.4143/crt.2017.320

Article  PubMed  Google Scholar 

Huggett MT, Passant H, Hurt C, Pereira SP, Bridgewater J, Mukherjee S (2014) Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United Kingdom. Tumori 100(2):219–224. https://doi.org/10.1177/030089161410000217

Article  PubMed  Google Scholar 

Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J et al (2014) Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS ONE 9(12):e115383. https://doi.org/10.1371/journal.pone.0115383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian W, Hu W, Shi X, Liu P, Ma X, Zhao W et al (2020) Comprehensive genomic profile of cholangiocarcinomas in China. Oncol Lett 19(4):3101–3110. https://doi.org/10.3892/ol.2020.11429

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waseem D, Tushar P (2017) Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes. Ann Hepatol 16(1):133–139. https://doi.org/10.5604/16652681.1226927

Article  PubMed  Google Scholar 

Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23(6):703–713. https://doi.org/10.1038/nm.4333

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. https://doi.org/10.1126/scisignal.2004088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M et al (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003–1010. https://doi.org/10.1038/ng.3375

Article  CAS  PubMed  Google Scholar 

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N et al (2017) Whole-genome and epigenomic landscapes of etiologically distinct subtypes of Cholangiocarcinoma. Cancer Discov 7(10):1116–1135. https://doi.org/10.1158/2159-8290.CD-17-0368

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E et al (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer. Cell 173(2):291–304e6. https://doi.org/10.1016/j.cell.2018.03.022

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J et al OncoKB: a Precision Oncology Knowledge Base. JCO Precis Oncol 2017;2017:PO.17.00011. https://doi.org/10.1200/PO.17.00011

Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17(9):557–588. https://doi.org/10.1038/s41575-020-0310-z

Article  PubMed  PubMed Central  Google Scholar 

Xue L, Guo C, Zhang K, Jiang H, Pang F, Dou Y et al (2019) Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in chinese population and potential targets for clinical practice. Hepatobiliary Surg Nutr 8(6):615–622. https://doi.org/10.21037/hbsn.2019.08.05

Article  PubMed  PubMed Central  Google Scholar 

Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M et al (2018) Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: potential targets for intervention. Clin Cancer Res 24(17):4154–4161. https://doi.org/10.1158/1078-0432.CCR-18-0078

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guest RV, Boulter L, Dwyer BJ, Kendall TJ, Man TY, Minnis-Lyons SE et al (2016) Notch3 drives development and progression of cholangiocarcinoma. Proc Natl Acad Sci U S A 113(43):12250–12255. https://doi.org/10.1073/pnas.1600067113

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Rourke CJ, Matter MS, Nepal C, Caetano-Oliveira R, Ton PT, Factor VM et al (2020) Identification of a pan-gamma-secretase inhibitor response signature for Notch-Driven Cholangiocarcinoma. Hepatology 71(1):196–213. https://doi.org/10.1002/hep.30816

Article  CAS  PubMed  Google Scholar 

Zhang Y, Ma Z, Li C, Wang C, Jiang W, Chang J et al (2022) The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nat Commun 13(1):3061. https://doi.org/10.1038/s41467-022-30708-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujimoto A, Furuta M, Shiraishi Y, Gotoh K, Kawakami Y, Arihiro K et al (2015) Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat Commun 6:6120. https://doi.org/10.1038/ncomms7120

Article  CAS  PubMed  Google Scholar 

Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM et al (2017) Common molecular subtypes among asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell 32(1):57–70e3. https://doi.org/10.1016/j.ccell.2017.05.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng F, Wu X, Shi X, Gao Q, Wu Y, Yu Y et al (2021) Comprehensive analysis of genomic alterations of chinese hilar cholangiocarcinoma patients. Int J Clin Oncol 26(4):717–727. https://doi.org/10.1007/s10147-020-01846-z

Article  CAS  PubMed  Google Scholar 

Khamko R, Wasenang W, Daduang J, Settasatian C, Limpaiboon T (2022) Combined OPCML and AXL expression as a prognostic marker and OPCML enhances AXL inhibitor in Cholangiocarcinoma. In Vivo 36(3):1168–1177. https://doi.org/10.21873/invivo.12816

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN et al (2022) AXL inhibition improves BRAF-targeted treatment in melanoma. Sci Rep 12(1):5076. https://doi.org/10.1038/s41598-022-09078-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong Y (2018) The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review. Onco Targets Ther 11:509–519. https://doi.org/10.2147/OTT.S150952

Article  PubMed  PubMed Central